Skip to Content

AtriCure Inc ATRC

Morningstar Rating
$23.10 +0.20 (0.87%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATRC is trading at a 35% discount.
Price
$23.05
Fair Value
$29.32
Uncertainty
Very High
1-Star Price
$34.65
5-Star Price
$69.56
Economic Moat
Zwc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATRC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$22.90
Day Range
$22.4223.35
52-Week Range
$22.4259.61
Bid/Ask
$22.01 / $35.23
Market Cap
$1.12 Bil
Volume/Avg
1.1 Mil / 723,643

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.00
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.59%

Company Profile

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
1,200

Comparables

Valuation

Metric
ATRC
MMSI
ZIMV
Price/Earnings (Normalized)
24.179.62
Price/Book Value
2.643.501.04
Price/Sales
3.003.380.91
Price/Cash Flow
52.7819.7312.20
Price/Earnings
ATRC
MMSI
ZIMV

Financial Strength

Metric
ATRC
MMSI
ZIMV
Quick Ratio
2.553.810.84
Current Ratio
3.575.452.78
Interest Coverage
−3.868.07−1.51
Quick Ratio
ATRC
MMSI
ZIMV

Profitability

Metric
ATRC
MMSI
ZIMV
Return on Assets (Normalized)
−5.85%9.43%14.12%
Return on Equity (Normalized)
−7.57%14.77%31.63%
Return on Invested Capital (Normalized)
−6.07%11.47%18.79%
Return on Assets
ATRC
MMSI
ZIMV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncPzznngfpYkfpf$134.2 Bil
BDX
Becton Dickinson & CoFmftrvfVqdyy$67.9 Bil
ALC
Alcon IncJwyhcxhnYwppddz$39.5 Bil
CLPBY
Coloplast A/S ADRQzphntzkgQxv$29.4 Bil
WST
West Pharmaceutical Services IncWkqrqcbfcgSkw$27.8 Bil
RMD
ResMed IncKllpnvdmryWndkgc$27.2 Bil
BAX
Baxter International IncPncnttdWntwr$20.2 Bil
COO
The Cooper Companies IncCwcvjjnrBxmsmq$18.0 Bil
HOLX
Hologic IncTcnzmsjmSlnpdw$17.6 Bil
TFX
Teleflex IncWwydpLcgqs$9.9 Bil

Sponsor Center